NCT00884325View on ClinicalTrials.gov

Management of Pruritus With Xyzal in Atopic Dermatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Atopic DermatitisPruritus
Interventions
DRUG

Levocetirizine dihydrochloride (Xyzal)

One tablet 5 mg taken orally at night for 28 days

DRUG

placebo

One tablet taken orally at night for 28 days

Trial Locations (1)

40217

DermResearch, PLLC, Louisville

Sponsors

Collaborators (1)

UCB Pharma
All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Derm Research, PLLC

OTHER